High Carbohydrate Antigen 19-9 Levels Indicate Poor Prognosis of Upper Tract Urothelial Carcinoma

被引:0
|
作者
Jeong, Seung-hwan [1 ]
Han, Jang Hee [1 ]
Jeong, Chang Wook [1 ,2 ]
Kim, Hyeon Hoe [1 ,2 ]
Kwak, Cheol [1 ,2 ]
Yuk, Hyeong Dong [1 ,2 ]
Ku, Ja Hyeon [1 ,2 ]
机构
[1] Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea
[2] Seoul Natl Univ, Dept Urol, Coll Med, Seoul, South Korea
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
基金
新加坡国家研究基金会;
关键词
CA; 19-9; UTUC; prognosis; survival; metastasis; ONCOLOGIC OUTCOMES; SERUM CA-19-9; CA19-9; MARKER; CEA;
D O I
10.3389/fonc.2022.858813
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Upper tract urothelial carcinoma (UTUC) occurs in urothelial cells from the kidney and the ureters. Carbohydrate antigen 19-9 (CA 19-9) is a tumor marker for pancreatic and gastrointestinal cancers, and its high levels are associated with poor prognosis in bladder cancer. In this study, prospective patients enrolled in the registry of Seoul National University were retrospectively examined to determine the clinical significance of CA 19-9 in UTUC. In 227 patients, high serum CA 19-9 levels reflected a high tumor burden represented by high T and N stages, leading to adverse prognosis in metastasis-free or overall survival. Subsequently, propensity score matching analysis showed that the CA 19-9 level is an independent prognostic factor of UTUC.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract
    Lee, Hsiang-Ying
    Yeh, Bi-Wen
    Chan, Ti-Chun
    Yang, Kei-Fu
    Li, Wei-Ming
    Huang, Chun-Nung
    Ke, Hung-Lung
    Li, Ching-Chia
    Yeh, Hsin-Chih
    Liang, Peir-In
    Shiue, Yow-Ling
    Wu, Wen-Jeng
    Li, Chien-Feng
    ONCOTARGET, 2017, 8 (29) : 47216 - 47229
  • [42] Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis
    Song, Yong-xi
    Huang, Xuan-zhang
    Gao, Peng
    Sun, Jing-xu
    Chen, Xiao-wan
    Yang, Yu-chong
    Zhang, Cong
    Liu, Hong-peng
    Wang, Hong-chi
    Wang, Zhen-ning
    DISEASE MARKERS, 2015, 2015
  • [43] INHBA Overexpression Indicates Poor Prognosis in Urothelial Carcinoma of Urinary Bladder and Upper Tract
    Lee, Hsiang-Ying
    Li, Ching-Chia
    Huang, Chun-Nung
    Li, Wei-Ming
    Yeh, Hsin-Chih
    Ke, Hung-Lung
    Yang, Kai-Fu
    Liang, Peir-In
    Li, Chien-Feng
    Wu, Wen-Jeng
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (04) : 414 - 422
  • [44] Colorectal carcinoma liver metastases: clinical significance of preoperative measurement of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels
    Ishizuka, D
    Shirai, Y
    Sakai, Y
    Hatakeyama, K
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2001, 16 (01) : 32 - 37
  • [45] Elevated carbohydrate antigen 19-9 in a dermoid cyst
    Atabekoglu, C
    Bozaci, EA
    Tezcan, S
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 91 (03) : 262 - 263
  • [46] Does the elevation of serum carbohydrate antigen 19-9 level predict poor overall survival in patients with hepatocellular carcinoma?
    Wang, Yan-Yan
    Zhong, Jian-Hong
    Lu, Zhan
    Qin, Hong-Gui
    Li, Le-Qun
    TUMOR BIOLOGY, 2015, 36 (11) : 8273 - 8274
  • [47] Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma
    Jiang, Tao
    Lyu, Shao-Cheng
    Zhou, Lin
    Wang, Jing
    Li, Han
    He, Qiang
    Lang, Ren
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 13 (09):
  • [48] CA19-9 as a serum marker for poor prognosis in urothelial carcinoma
    Sashide, K
    Isobe, H
    Wakumoto, Y
    Hanazawa, K
    Fujita, K
    Fujime, M
    UROLOGIA INTERNATIONALIS, 2004, 72 (02) : 112 - 117
  • [49] Increased carbohydrate antigen 19-9 expression in a thymic neuroendocrine tumor
    Shimizu, Yuki
    Kanda, Shintaro
    Fukushima, Toshirou
    Kobayashi, Takashi
    Kondo, Ryoichi
    Koizumi, Tomonobu
    THORACIC CANCER, 2021, 12 (21) : 2949 - 2952
  • [50] Predictive Factors for Elevated Postoperative Carbohydrate Antigen 19-9 Levels in Patients With Resected Pancreatic Cancer
    Takagi, Chisato
    Kikuchi, Yutaro
    Shirakawa, Hirofumi
    Hoshimoto, Sojun
    Tomikawa, Moriaki
    Ozawa, Iwao
    Hishinuma, Shoichi
    Ogata, Yoshiro
    ANTICANCER RESEARCH, 2019, 39 (06) : 3177 - 3183